002020.SZ Stock Analysis
00
Neutral
Based on Eyestock quantitative analysis, 002020.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Undervalued
Zhejiang Jingxin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of active pharmaceutical ingredients and medical devices. The company is headquartered in Shaoxing, Zhejiang and currently employs 3,490 full-time employees. The company went IPO on 2004-07-15. The firm's pharmaceutical products include chemical pharmaceuticals, traditional medicines, biological agents and bulk pharmaceutical chemicals. Its pharmaceutical products are mainly applied in cardiovascular sector, digestive tract sector and psychoneural sector, among others. The firm is also engaged in the research and development, manufacture and sales of medical devices. Its medical devices include clinical displays, diagnosis displays, endoscopic surgery displays and ultrasonic image displays, among others. The firm operates its businesses in both domestic and overseas markets.